Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Datamonitors' SpePharm Holding B.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by SpePharm Holding B.V. since January 2007.
– Provides intelligence on SpePharm Holding B.V.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by SpePharm Holding B.V. and its subsidiaries since 2007. – Information about key financial and legal advisors for SpePharm Holding B.V.'s financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
This report includes SpePharm Holding B.V.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by SpePharm Holding B.V.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about SpePharm Holding B.V.’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
The Europe cancer vaccines market was valued at US$ 1,387.2 million in 2019 and is projected to reach US$ 4,680.7 million by 2027; it is expected to grow at a CAGR of 15.4% during 2020–2027. Increasing number of cancer patients, emergence of market players operating in the cancer vaccines market and robust research and development activities...
Bronchiectasis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Pipeline Review, H2 2020, provides an overview of the Bronchiectasis (Respiratory) pipeline landscape. Bronchiectasis is a chronic condition where the walls of...
Cataract - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cataract - Pipeline Review, H2 2020, provides an overview of the Cataract (Ophthalmology) pipeline landscape. Cataract is a clouding of the normally clear lens of eye that affects vision....
Oropharyngeal Cancer - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Oropharyngeal Cancer - Pipeline Review, H2 2020, provides an overview of the Oropharyngeal Cancer (Oncology) pipeline landscape. Oropharyngeal cancer is a disease which...
Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Transdermal Drug Delivery Devicess pipeline products with...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.